Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EEG and CT abnormalities in xeroderma pigmentosum.

T Mimaki1, T Tagawa, J Tanaka

  • 1Department of Pediatrics, Osaka University Medical School.

Acta Neurologica Scandinavica
|August 1, 1989
PubMed
Summary

Xeroderma pigmentosum (XP) group A is linked to neurological issues. This study found that neurological complications, including sensorineural deafness and spinocerebellar signs, worsen with age, suggesting a progressive neurodegenerative disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of lipid content on virtual non-contrast images and iodine density estimation from dual-layer spectral computed tomography: A phantom study.

Radiography (London, England : 1995)·2026
Same author

SU-E-I-59: Investigation of the Usefulness of a Standard Deviation and Mammary Gland Density as Indexes for Mammogram Classification.

Medical physics·2017
Same author

SU-E-I-62: Investigation of Dominant Factors Affecting Fatigue in Image Reading of Radiologists.

Medical physics·2017
Same author

Re: Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT. A reply.

Clinical radiology·2016
Same author

Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.

Clinical radiology·2015
Same author

Low-dose CT screening using hybrid iterative reconstruction: confidence ratings of diagnoses of simulated lesions other than lung cancer.

The British journal of radiology·2015

Area of Science:

  • Neuroscience
  • Genetics
  • Dermatology

Background:

  • Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by defective DNA repair.
  • XP group A is associated with significant neurological abnormalities, often presenting as a neurocutaneous disorder.
  • The progressive nature and specific neurological manifestations of XP group A require further elucidation.

Purpose of the Study:

  • To assess the spectrum and progression of neurological complications in patients with Xeroderma pigmentosum group A.
  • To correlate clinical findings with electrophysiological (EEG) and neuroimaging (CT scan) data.
  • To determine if XP group A represents a chronic progressive neurodegenerative disease.

Main Methods:

  • Retrospective analysis of 35 patients diagnosed with Xeroderma pigmentosum group A.

Related Experiment Videos

  • Clinical neurological examinations focusing on microcephaly, mental retardation, sensorineural deafness, and spinocerebellar signs.
  • Electroencephalography (EEG) and cranial computed tomography (CT) scans were performed and analyzed.

    • Main Results:

    • Seventeen patients had microcephaly, and 24 had mental retardation.
    • In patients over 7 years old, 22 exhibited sensorineural deafness and 12 showed spinocerebellar signs (nystagmus, dysarthria, tremor, ataxia).
    • Abnormal EEG and CT findings, including ventricular dilatation and cortical atrophy, were more prevalent in older patients, correlating with neurological decline.

    Conclusions:

    • Neurological complications in Xeroderma pigmentosum group A, particularly sensorineural deafness and spinocerebellar signs, increase with age.
    • EEG and CT findings suggest ongoing central nervous system (CNS) degeneration.
    • XP group A should be considered a chronic progressive neurodegenerative disorder affecting the CNS.